Chemotherapy for known residual disease after resection of gastric and colorectal cancer.
D002272:Carcinoembryonic Antigen / Q000032:analysis; D002330:Carmustine / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000276:immunology; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D012673:Semustine / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000601:surgery
D002272:Carcinoembryonic Antigen; D009607:Nitrosourea Compounds; D012673:Semustine; D005472:Fluorouracil; D002330:Carmustine